Cargando…
Multiple primary malignancies involving lung cancer
BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606552/ https://www.ncbi.nlm.nih.gov/pubmed/26466785 http://dx.doi.org/10.1186/s12885-015-1733-8 |
_version_ | 1782395371743346688 |
---|---|
author | Li, Feng Zhong, Wen-Zhao Niu, Fei-Yu Zhao, Ning Yang, Jin-Ji Yan, Hong-Hong Wu, Yi-Long |
author_facet | Li, Feng Zhong, Wen-Zhao Niu, Fei-Yu Zhao, Ning Yang, Jin-Ji Yan, Hong-Hong Wu, Yi-Long |
author_sort | Li, Feng |
collection | PubMed |
description | BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics and prognosis of MPM patients involving lung cancer in the People’s Republic of China. METHODS: Of 5405 lung cancer cases diagnosed at the Guangdong Lung Cancer Institute between 2005 and 2013, we analyzed 185 patients (3.4 %) with MPM involving lung cancer. RESULTS: Among 185 patients with MPM involving lung cancer, 10 (5.4 %)had three malignancies and 175 (94.6 %) had two malignancies. 10 patients with three malignancies were excluded from the analysis to avoid misunderstanding. Of 175 accompanying malignancies, 64 (36.6 %) were synchronous MPM patients and 111 (63.4 %) were metachronous MPM patients; 49 (28.0 %) were lung cancer first MPM patients and 126 (72.0 %) were other cancer first MPM patients. The most frequent accompanying malignancy was colon cancer (25/175), followed by rectal cancer (18/175), esophageal cancer (17/175), and thyroid cancer (13/175). Metachronous MPM patients showed significantly better overall survival (OS) than synchronous MPM, with a median OS of 72.8 (range 12.2–391.0) and 12.9 (range 0.8–86.3)months, respectively (P < 0.001). Cox regression analysis revealed that time of occurrence and stage were independent factors for OS. CONCLUSIONS: Colorectal cancer, esophageal cancer, and thyroid cancer were the tumors that most frequently accompanying lung cancer. Metachronous MPM patients showed significantly better OS compared with synchronous MPM patients. |
format | Online Article Text |
id | pubmed-4606552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46065522015-10-16 Multiple primary malignancies involving lung cancer Li, Feng Zhong, Wen-Zhao Niu, Fei-Yu Zhao, Ning Yang, Jin-Ji Yan, Hong-Hong Wu, Yi-Long BMC Cancer Research Article BACKGROUND: The incidence of multiple primary malignancies (MPM) has increased sharply in recent decades. However, the clinical characteristics and prognosis of MPM patients involving lung cancer were not fully elucidated. This retrospective study was designed to explore the clinical characteristics and prognosis of MPM patients involving lung cancer in the People’s Republic of China. METHODS: Of 5405 lung cancer cases diagnosed at the Guangdong Lung Cancer Institute between 2005 and 2013, we analyzed 185 patients (3.4 %) with MPM involving lung cancer. RESULTS: Among 185 patients with MPM involving lung cancer, 10 (5.4 %)had three malignancies and 175 (94.6 %) had two malignancies. 10 patients with three malignancies were excluded from the analysis to avoid misunderstanding. Of 175 accompanying malignancies, 64 (36.6 %) were synchronous MPM patients and 111 (63.4 %) were metachronous MPM patients; 49 (28.0 %) were lung cancer first MPM patients and 126 (72.0 %) were other cancer first MPM patients. The most frequent accompanying malignancy was colon cancer (25/175), followed by rectal cancer (18/175), esophageal cancer (17/175), and thyroid cancer (13/175). Metachronous MPM patients showed significantly better overall survival (OS) than synchronous MPM, with a median OS of 72.8 (range 12.2–391.0) and 12.9 (range 0.8–86.3)months, respectively (P < 0.001). Cox regression analysis revealed that time of occurrence and stage were independent factors for OS. CONCLUSIONS: Colorectal cancer, esophageal cancer, and thyroid cancer were the tumors that most frequently accompanying lung cancer. Metachronous MPM patients showed significantly better OS compared with synchronous MPM patients. BioMed Central 2015-10-14 /pmc/articles/PMC4606552/ /pubmed/26466785 http://dx.doi.org/10.1186/s12885-015-1733-8 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Li, Feng Zhong, Wen-Zhao Niu, Fei-Yu Zhao, Ning Yang, Jin-Ji Yan, Hong-Hong Wu, Yi-Long Multiple primary malignancies involving lung cancer |
title | Multiple primary malignancies involving lung cancer |
title_full | Multiple primary malignancies involving lung cancer |
title_fullStr | Multiple primary malignancies involving lung cancer |
title_full_unstemmed | Multiple primary malignancies involving lung cancer |
title_short | Multiple primary malignancies involving lung cancer |
title_sort | multiple primary malignancies involving lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606552/ https://www.ncbi.nlm.nih.gov/pubmed/26466785 http://dx.doi.org/10.1186/s12885-015-1733-8 |
work_keys_str_mv | AT lifeng multipleprimarymalignanciesinvolvinglungcancer AT zhongwenzhao multipleprimarymalignanciesinvolvinglungcancer AT niufeiyu multipleprimarymalignanciesinvolvinglungcancer AT zhaoning multipleprimarymalignanciesinvolvinglungcancer AT yangjinji multipleprimarymalignanciesinvolvinglungcancer AT yanhonghong multipleprimarymalignanciesinvolvinglungcancer AT wuyilong multipleprimarymalignanciesinvolvinglungcancer |